ArticleAdvances in therapy2024

Long-Term Comparative Efficacy and Safety of Risdiplam and Nusinersen in Children with Type 1 Spinal Muscular Atrophy.

Christos Kokaliaris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.